Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AR tech could make lung surgery less painful and cheaper

NCT ID NCT06548451

Symptom relief Sponsor: Shanghai Chest Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether augmented reality (AR) can help surgeons locate small lung nodules during surgery, compared to the standard CT-guided hook-wire method. 270 patients with lung cancer were enrolled across multiple centers. The goal was to see if AR could make the procedure faster, less painful, and more cost-effective.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Augmented reality device
What this could lead to
If successful, this could make lung nodule localization faster, less painful, and cheaper, improving surgical outcomes for lung cancer patients.
What could go wrong
This is a completed trial, but the technology may not be widely adopted due to cost or training needs. It only helps with localization, not treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

270 people

The number who actually took part.

Started

Aug 2024

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age between 18 and 80 years inclusive; 2. No distant metastasis in preoperative clinical assessment; 3. The attending physician's assessment confirms the need for lung nodule localization in patients undergoing sublobar resection; 4. Target lung nodule diameter is no more than 2 cm; 5. The inner edge of the target nodule is at least 2 cm away from the pulmonary artery or pulmonary vein; 6. Non-pleural surface nodules; 7. Preoperative ECOG performance status score of 0/1; 8. Voluntarily participating in this study and signing an informed consent form. Exclusion Criteria: 1. More than two lung nodules need to be removed at the same time. 2. The target node is located in the scapular region. Because percutaneous localization is obstructed by the scapula, percutaneous localization of pulmonary nodules is not suitable for such patients. 3. Patients with chronic pain issues or those who have been taking pain medications for an extended period. 4. Patients have uncontrollable mental illness and cannot make subjective assessment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lung cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm pulmonary coin lesion

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lung cancer

Contacts and locations

Locations

  • Donghai County People's Hospital

    Lianyungang, China

  • Jiangyin Hospital of Traditional Chinese Medicine

    Jiangyin, China

  • Jining No. 1 People's Hospital.

    Jining, China

  • Shanghai Chest Hospital

    Shanghai, Shanghai Municipality, 200030, China

  • Zhangjiagang Hospital of Traditional Chinese Medicine,

    Zhangjiagang, China

  • Zhongshan Hospital

    Shanghai, Shanghai Municipality, 200030, China

  • the First Hospital of Hebei Medical University

    Shijia Zhuang, China

  • the people's second hospital Hefei

    Hefei, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.